Constraint-Induced (CI) Movement Therapy for Progressive Multiple Sclerosis (MS)

Constraint-Induced Movement Therapy Trial for Progressive Multiple Sclerosis

This trial will evaluate whether progressive multiple sclerosis associated with hemiparesis may benefit from Constraint-Induced Movement Therapy.

Constraint-Induced Movement Therapy was developed to treat stroke hemiparesis. Due to the similarity between multiple sclerosis and stroke in terms of chronic motor deficit, this trial will attempt to determine whether multiple sclerosis may benefit similarly from Constraint-Induced Movement Therapy.

Inclusion Criteria:

• Chronic upper extremity motor deficit due to multiple sclerosis

Exclusion Criteria:

• Relapse within 3 months of planned enrollment.